TCL Archive In Brief: FDA Oncological Drugs Advisory Committee Gets New Charter, Georgetown’s Schein Is Chairman October 13, 1978
TCL Archive Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study December 31, 2010
TCL Archive National Cancer Act Of 1971 Commemorated In Symposium Marking Progress, Future Goals December 13, 1991
TCL Archive Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar January 10, 2003
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
